Author:
Wen Z.-H.,Tang C.-C.,Chang Y.-C.,Huang S.-Y.,Chen C.-H.,Wu S.-C.,Hsieh S.-P.,Hsieh C.-S.,Wang K.-Y.,Lin S.-Y.,Lee H.-L.,Lee C.-H.,Kuo H.-C.,Chen W.-F.,Jean Y.-H.
Subject
Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology
Reference51 articles.
1. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets;Pelletier;Arthritis Rheum,2001
2. Clinical pharmacokinetics of meloxicam;Türck;Arzneimittelforschung,1997
3. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2;Engelhardt;Br J Rheumatol,1996
4. The advent of highly selective inhibitors of cyclooxygenase-2, a review;Cryer;Prostaglandins Other Lipid Mediators,1998
5. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs;Patrignani;J Physiol Pharmacol,1997
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献